Boost for medical software company PathXL after contract wins
Belfast medical software company PathXL has seen its turnover rise 45% as a result of several new contracts won during the past year.
The firm creates software for medical researchers to process slides and provides software for use in research, healthcare and education.
During the past 12 months, the company secured contracts with 21 new customers and saw 6,000 new users of its services. The boost brought the total number of people using the firm's software to around 50,000 worldwide.
Earlier this year, PathXL announced that it would create 32 new jobs as part of a £3.6m expansion.
Chief executive Des Speed said: "This continued success is the result of our commitment to driving innovation in the digital pathology landscape and the tireless commitment from our teams to provide true excellence in customer service."
"These relationships are the key reason why our products continue to develop rapidly, meeting the exciting future that digital pathology offers. We are truly proud to be doing our part to make a difference."
The company has also been ranked in the 50 fastest-growing technology firms in Ireland by Deloitte for four years in a row, and this year it was the sole recipient of the Deloitte research and development award.
PathXL has also seen an increase in the number of user licences across its existing customer base as institutions expand their digital offering to meet internal demand for imaging and analysis.
The firm's TissueMark software assists the automated detection and measurement of tumours. The technology, which supports tissue quality evaluation, has recently been awarded its first patent.